-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: keymaster@town.hall.org Originator-Key-Asymmetric: MFkwCgYEVQgBAQICAgADSwAwSAJBALeWW4xDV4i7+b6+UyPn5RtObb1cJ7VkACDq pKb9/DClgTKIm08lCfoilvi9Wl4SODbR1+1waHhiGmeZO8OdgLUCAwEAAQ== MIC-Info: RSA-MD5,RSA, rAxM9u0jTlfrjtyD2IOKMRhVUl7EgvJBhQ0qu4Jay3ZHLyA1B66o7GN9ewOylkL7 5BzNyxcNcpR9xuO5XUxxVg== 0000950115-95-000008.txt : 19950607 0000950115-95-000008.hdr.sgml : 19950607 ACCESSION NUMBER: 0000950115-95-000008 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 19950120 ITEM INFORMATION: Acquisition or disposition of assets FILED AS OF DATE: 19950126 SROS: AMEX FILER: COMPANY DATA: COMPANY CONFORMED NAME: MEDIQ INC CENTRAL INDEX KEY: 0000350920 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-MISC HEALTH & ALLIED SERVICES, NEC [8090] IRS NUMBER: 510219413 STATE OF INCORPORATION: DE FISCAL YEAR END: 0930 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-08147 FILM NUMBER: 95503019 BUSINESS ADDRESS: STREET 1: ONE MEDIQ PLZ CITY: PENNSAUKEN STATE: NJ ZIP: 08110 BUSINESS PHONE: 6096656300 MAIL ADDRESS: STREET 1: ONE MEDIQ PLZ CITY: PENNSAUKEN STATE: NJ ZIP: 08110 8-K 1 CURRENT REPORT SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 ------------------------ FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15 (d) of the Securities Exchange Act of 1934 DATE OF REPORT --January 20, 1995 (Date of earliest event reported) MEDIQ INCORPORATED (Exact name of Registrant as specified in its charter) DELAWARE 1-8147 51-0219413 (State of incorporation) (Commission file number) (IRS employer identification number)
ONE MEDIQ PLAZA, PENNSAUKEN, NJ 08110 (Address of principal executive offices, zip code) AREA CODE (609) 665-9300 (Telephone number) ITEM 5. OTHER EVENTS. The Registrant announced on January 20, 1995 that its Board of Directors has formed a Special Committee for the purpose of exploring alternate ways to maximize shareholder value. Among those matters to be considered by the Special Committee are the possible sale of all or substantially all the stock or assets of MEDIQ, its wholly-owned subsidiaries or its interests in its partially owned subsidiaries to a buyer or group of buyers, which may include members of the management of MEDIQ and its subsidiaries. The Special Committee has retained the investment banking firm of Lazard Freres & Co. to act as its exclusive financial advisor to assist it in considering these alternatives. MEDIQ does not presently intend to make any additional public announcements with respect to these matters until such time as its Special Committee concludes its review of the alternative ways to enhance shareholder value. ITEM 7. FINANCIAL STATEMENTS AND EXHIBITS.
PAGE ----- (c) Exhibits 99 Press Release, dated January 20, 1995. 3
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. MEDIQ Incorporated____________________ (Registrant) /S/__MICHAEL F. SANDLER_______________ Michael F. Sandler Senior Vice President -- Finance & Chief Financial Officer Date: January 25, 1995 EX-99 2 PRESS RELEASE NEWS RELEASE January 20, 1995 BERNARD J. KORMAN President/Chief Executive Officer MEDIQ Incorporated (609) 665-9300 MEDIQ INCORPORATED ANNOUNCES FORMATION OF SPECIAL COMMITTEE TO EXPLORE WAYS TO ENHANCE SHAREHOLDER VALUE PENNSAUKEN, NJ -- MEDIQ Incorporated, a healthcare services company, today announced that its Board of Directors has formed a Special Committee for the purpose of exploring alternative ways to maximize shareholder value. Among those matters to be considered by the Special Committee are the possible sale of all or substantially all the stock or assets of MEDIQ, its wholly-owned subsidiaries or its interests in its partially owned subsidiaries to a buyer or group of buyers, which may include members of the management of MEDIQ and its subsidiaries. The Special Committee has retained the investment banking firm of Lazard Freres & Co. to act as its exclusive financial advisor to assist it in considering these alternatives. MEDIQ does not presently intend to make any additional public announcements with respect to these matters until such time as its Special Committee concludes its review of the alternative ways to enhance shareholder value. MEDIQ Incorporated, whose shares (MED and MED:Pr) and debentures (MED:C and MED:NP) are traded on the American Stock Exchange, provides essential healthcare services in a cost effective manner to a variety of healthcare providers. MEDIQ's principal business is MEDIQ/PRN, the country's leading provider of life support and critical care medical equipment on a rental basis. Other MEDIQ operations include portable x-ray, nuclear imaging and ultrasound services; healthcare facility planning, design and project management and utilization review of medical claims made to insurance companies. MEDIQ also owns 47% of PCI Services, Inc. (NASDAQ:PCIS), a leading independent provider of pharmaceutical packaging services; 47% of NutraMax Products, Inc. (NASDAQ:NMPC), a leading health and personal care products company, marketing products in the feminine needs, cough/cold, baby care, eye care and personal care categories; and 40% of MMI Medical, Inc. (NASDAQ:MMIM), a leading independent provider of cost-effective specialized services to hospital radiology departments and other healthcare providers. -----END PRIVACY-ENHANCED MESSAGE-----